Plaque Stabilization and Restoration by Bioresorbable Vascular Scaffold

Inclusion Criteria: * Symptomatic patients between the age of 18 and 80 years * Morise Risk score of ≥9 (intermediate or high risk) but no proven ischemia (no positive troponin or ST-elevation) * Intermediate coronary lesion on CT scan (50-70% based on CT estimate) and a plaque with at least two of the following vulnerability criteria: Napkin ring sign, positive remodeling, low attenuation and spotty calcification * FFR negative lesion at coronary angiogram * Vessel diameter ≥2.5 mm on visual estimate * GFR ≥ 45mL/min/1.73m². Exclusion Criteria: * High calcium score on CT scan preventing adequate evaluation of the coronary lesion. * Lesions located in a coronary vessels previously stented. * Lesions located at a bifurcation * lesions involving an epicardial side branch ≥2 mm in diameter by visual assessment * the presence of thrombus or another clinically significant stenosis in the target vessel. * Left main (\>50%) or known three vessel disease. * Patients presenting with acute myocardial infarction, unstable arrhythmias, or patients who have a left ventricular ejection fraction \<30% * Intolerance to Aspirin, Clopidogrel, Prasugrel, Ticagrelor, Heparine or Everolimus and known true anaphylaxis to prior contrast media or known bleeding diathesis or known coagulopathy. * Planned elective surgical procedure necessitating interruption of dual antiplatelet therapy during the first 6 months after inclusion. * History of stent thrombosis * Malignancies or other comorbidity with a life expectancy of less than one year or that may result in protocol noncompliance * Pregnancy (present, suspected or planned) or positive pregnancy test (in women with childbearing potential a negative pregnancy test is mandatory)